SKOLNICK PHIL (Chief Scientific Officer) sold 6.0% of their position (1.42K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $28.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2023ACC: 0001385508-23-000007
Officer· Chief Scientific Officer
Since Oct 2018
-1.42K
Net shares
Net seller
$28.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.42K
Price / share
$20.20
Trade value
$28.70K
% of position
6.0%
1/5/2023
23.82K→22.40K
Total
Net shares
−1.42K
Net value
-$28.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2023 | S · Sale | −1.42K | $20.20 | $28.70K | 6.0% | 23.82K | 22.40K |
| Total | −1.42K | -$28.70K | ||||||
Derivative Transactions0
No derivative transactions reported